|
1
|
Burkauskas J, Fineberg NA, Ioannidis K, Chamberlain SR, Bowden-Jones H, Griskova-Bulanova I, Pranckeviciene A, Dores AR, Carvalho IP, Barbosa F, Simonato P, De Luca I, Mooney R, Gómez-Martínez MÁ, Demetrovics Z, Ábel KE, Szabo A, Fujiwara H, Shibata M, Melero-Ventola AR, Arroyo-Anlló EM, Santos-Labrador RM, Kobayashi K, Di Carlo F, Monteiro C, Martinotti G, Corazza O. Online Behaviours during the COVID-19 Pandemic and Their Associations with Psychological Factors: An International Exploratory Study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19148823. [PMID: 35886679 PMCID: PMC9323465 DOI: 10.3390/ijerph19148823] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 05/28/2022] [Revised: 07/05/2022] [Accepted: 07/15/2022] [Indexed: 12/24/2022]
Abstract
This cross-sectional study aimed to explore specific online behaviours and their association with a range of underlying psychological and other behavioural factors during the COVID-19 pandemic. Eight countries (Italy, Spain, the United Kingdom, Lithuania, Portugal, Japan, Hungary, and Brazil) participated in an international investigation involving 2223 participants (M = 33 years old; SD = 11), 70% of whom were females. Participants were surveyed for specific type of Internet use severity, appearance anxiety, self-compassion, and image and use of performance-enhancing drugs (IPEDs). Results were compared cross-culturally. The mean time spent online was 5 h (SD = ±3) of daily browsing during the pandemic. The most commonly performed activities included social networking, streaming, and general surfing. A strong association between these online behaviours and appearance anxiety, self-compassion, and IPEDs use was found after adjustment for possible confounders, with higher scores being associated with specific online activities. Significant cross-cultural differences also emerged in terms of the amount of time spent online during the initial stages of the COVID-19 pandemic.
Collapse
Affiliation(s)
- Julius Burkauskas
- Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, 00135 Palanga, Lithuania;
- Correspondence: ; Tel.: +370-612-04885
| | - Naomi A. Fineberg
- Department of Clinical, Pharmaceutical and Biological Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9EU, UK; (N.A.F.); (P.S.); (I.D.L.); (G.M.); (O.C.)
| | - Konstantinos Ioannidis
- Department of Psychiatry, University of Cambridge, Cambridge CB2 1TN, UK; (K.I.); (H.B.-J.)
- Department of Psychiatry, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK
- Southern Health NHS Foundation Trust, Southampton SO40 2RZ, UK
| | - Samuel R. Chamberlain
- Department of Psychiatry, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK
- Southern Health NHS Foundation Trust, Southampton SO40 2RZ, UK
| | - Henrietta Bowden-Jones
- Department of Psychiatry, University of Cambridge, Cambridge CB2 1TN, UK; (K.I.); (H.B.-J.)
| | - Inga Griskova-Bulanova
- Department of Neurobiology and Biophysics, Institute of Biosciences, Vilnius University, 03225 Vilnius, Lithuania;
| | - Aiste Pranckeviciene
- Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, 00135 Palanga, Lithuania;
| | - Artemisa R. Dores
- School of Health, Polytechnic of Porto, 4200-072 Porto, Portugal;
- Laboratory of Neuropsychophysiology, Faculty of Psychology and Education Sciences, University of Porto, 4200-135 Porto, Portugal;
| | - Irene P. Carvalho
- Clinical Neurosciences and Mental Health Department, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal;
- CINTESIS@RISE, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal
| | - Fernando Barbosa
- Laboratory of Neuropsychophysiology, Faculty of Psychology and Education Sciences, University of Porto, 4200-135 Porto, Portugal;
| | - Pierluigi Simonato
- Department of Clinical, Pharmaceutical and Biological Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9EU, UK; (N.A.F.); (P.S.); (I.D.L.); (G.M.); (O.C.)
| | - Ilaria De Luca
- Department of Clinical, Pharmaceutical and Biological Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9EU, UK; (N.A.F.); (P.S.); (I.D.L.); (G.M.); (O.C.)
| | - Rosin Mooney
- Medical Sciences Division, Department of Psychiatry, University of Oxford, Oxford OX1 3TG, UK;
| | | | - Zsolt Demetrovics
- Centre of Excellence in Responsible Gaming, University of Gibraltar, Gibraltar GX11 1AA, Gibraltar;
- Institute of Psychology, ELTE Eötvös Loránd University, 1117 Budapest, Hungary; (K.E.Á.); (A.S.)
| | - Krisztina Edina Ábel
- Institute of Psychology, ELTE Eötvös Loránd University, 1117 Budapest, Hungary; (K.E.Á.); (A.S.)
| | - Attila Szabo
- Institute of Psychology, ELTE Eötvös Loránd University, 1117 Budapest, Hungary; (K.E.Á.); (A.S.)
- Institute of Health Promotion and Sport Sciences, ELTE Eötvös Loránd University, 1117 Budapest, Hungary
| | - Hironobu Fujiwara
- Department of Neuropsychiatry, Graduate School of Medicine, University of Kyoto, Kyoto 606-8501, Japan; (H.F.); (M.S.); (K.K.)
- Artificial Intelligence Ethics and Society Team, RIKEN Center for Advanced Intelligence Project, Saitama 103-0027, Japan
- General Research Division, Research Center on Ethical, Legal and Social Issues, Osaka University, Suita, Osaka 565-0871, Japan
| | - Mami Shibata
- Department of Neuropsychiatry, Graduate School of Medicine, University of Kyoto, Kyoto 606-8501, Japan; (H.F.); (M.S.); (K.K.)
| | - Alejandra R. Melero-Ventola
- Department of Psychology, Pontifical University of Salamanca, 37002 Salamanca, Spain; (M.Á.G.-M.); (A.R.M.-V.)
| | - Eva M. Arroyo-Anlló
- Department of Psychobiology, Neuroscience Institute of Castilla-León, University of Salamanca, 37002 Salamanca, Spain;
| | - Ricardo M. Santos-Labrador
- Department of Physical Education, University Teacher’s College ‘Fray Luis de León’, 47010 Valladolid, Spain;
| | - Kei Kobayashi
- Department of Neuropsychiatry, Graduate School of Medicine, University of Kyoto, Kyoto 606-8501, Japan; (H.F.); (M.S.); (K.K.)
| | - Francesco Di Carlo
- Department of Neuroscience, Imaging and Clinical Science “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy;
| | - Cristina Monteiro
- Department of Psychometrics, Institute of Psychology, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil;
| | - Giovanni Martinotti
- Department of Clinical, Pharmaceutical and Biological Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9EU, UK; (N.A.F.); (P.S.); (I.D.L.); (G.M.); (O.C.)
- Department of Neuroscience, Imaging and Clinical Science “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy;
| | - Ornella Corazza
- Department of Clinical, Pharmaceutical and Biological Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9EU, UK; (N.A.F.); (P.S.); (I.D.L.); (G.M.); (O.C.)
| |
Collapse
|